|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn923283031 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s2009 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d LIP
|d OCLCF
|d ZCU
|d OCLCO
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d ICG
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|d OCLCA
|d OCLCL
|
| 019 |
|
|
|a 990753808
|
| 020 |
|
|
|a 9780309163255
|
| 020 |
|
|
|a 0309163250
|
| 020 |
|
|
|a 0309163242
|
| 020 |
|
|
|a 9780309163248
|
| 029 |
1 |
|
|a DEBBG
|b BV044109176
|
| 035 |
|
|
|a (OCoLC)923283031
|z (OCoLC)990753808
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a R853.B54.M33 2011eb
|
| 082 |
0 |
4 |
|a 610.28
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Mack, Alison.
|
| 245 |
1 |
0 |
|a Perspectives on Biomarker and Surrogate Endpoint Evaluation :
|b Discussion Forum Summary.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 2009.
|
| 300 |
|
|
|a 1 online resource (141 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""FrontMatter""; ""Reviewers""; ""Contents""; ""1 Introduction""; ""2 Committee Findings and Recommendations""; ""3 FDA Perspectives""; ""4 National Institutes of Health Perspectives""; ""5 Industry Perspectives""; ""6 Public Health, Consumer, and Consulting Organization Perspectives""; ""7 Presentation by Thomas Fleming: Biomarkers and Surrogate Endpoints in Chronic Disease""; ""8 Key Themes, Challenges, and Opportunities""; ""9 Importance of the Biomarker Discussion Forum""; ""References""; ""Acronyms""; ""Glossary""; ""Appendix A: Discussion Forum Agenda""
|
| 500 |
|
|
|a ""Appendix B: Summary from the Committee�s Report *Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease*""
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Biochemical markers
|z United States
|x Evaluation.
|
| 650 |
|
0 |
|a Drugs
|x Testing.
|
| 650 |
|
0 |
|a Clinical trials.
|
| 650 |
|
0 |
|a Chronic diseases.
|
| 650 |
|
0 |
|a Medical personnel.
|
| 650 |
|
0 |
|a Diseases.
|
| 650 |
|
0 |
|a Evidence-based medicine.
|
| 650 |
|
2 |
|a Health Occupations
|
| 650 |
|
2 |
|a Disease Attributes
|
| 650 |
|
2 |
|a Pathologic Processes
|
| 650 |
|
2 |
|a Disciplines and Occupations
|
| 650 |
|
2 |
|a Pathological Conditions, Signs and Symptoms
|
| 650 |
|
2 |
|a Disease
|
| 650 |
|
2 |
|a Evidence-Based Practice
|
| 650 |
|
2 |
|a Chronic Disease
|
| 650 |
|
2 |
|a Clinical Trials as Topic
|
| 650 |
|
2 |
|a Health Personnel
|
| 650 |
|
2 |
|a Health Workforce.
|
| 650 |
|
2 |
|a Evidence-Based Medicine
|
| 650 |
|
6 |
|a Marqueurs biologiques
|z États-Unis
|x Évaluation.
|
| 650 |
|
6 |
|a Médicaments
|x Essais cliniques.
|
| 650 |
|
6 |
|a Études cliniques.
|
| 650 |
|
6 |
|a Maladies chroniques.
|
| 650 |
|
6 |
|a Personnel médical.
|
| 650 |
|
6 |
|a Maladies.
|
| 650 |
|
6 |
|a Médecine factuelle.
|
| 650 |
|
7 |
|a illness.
|2 aat
|
| 650 |
|
7 |
|a disease.
|2 aat
|
| 650 |
|
7 |
|a Medical personnel
|2 fast
|
| 650 |
|
7 |
|a Evidence-based medicine
|2 fast
|
| 650 |
|
7 |
|a Diseases
|2 fast
|
| 650 |
|
7 |
|a Biochemical markers
|x Evaluation
|2 fast
|
| 650 |
|
7 |
|a Chronic diseases
|2 fast
|
| 650 |
|
7 |
|a Clinical trials
|2 fast
|
| 650 |
|
7 |
|a Drugs
|x Testing
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 700 |
1 |
|
|a Balogh, Erin.
|
| 758 |
|
|
|i has work:
|a Perspectives on biomarker and surrogate endpoint evaluation (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGX67p9gDVBhWCTjmPtrmd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Mack, Alison.
|t Perspectives on Biomarker and Surrogate Endpoint Evaluation : Discussion Forum Summary.
|d Washington : National Academies Press, ©2009
|z 9780309163248
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378736
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3378736
|
| 994 |
|
|
|a 92
|b IZTAP
|
